ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 21 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,304,000 | +90.6% | 176,514 | 0.0% | 0.10% | +77.6% |
| Q2 2016 | $1,209,000 | -23.5% | 176,514 | +5.6% | 0.06% | -24.7% |
| Q1 2016 | $1,580,000 | -33.8% | 167,185 | -29.5% | 0.08% | -31.9% |
| Q4 2015 | $2,387,000 | +57.0% | 237,070 | +123.2% | 0.11% | +43.0% |
| Q3 2015 | $1,520,000 | – | 106,201 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |